Ondine Biomedical Inc. is seeking a pre-NDA meeting with the FDA regarding LANTERN results while conducting clinical trials in the US and Canada.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ondine Biomedical Inc. is seeking a pre-NDA meeting with the FDA regarding LANTERN results while conducting clinical trials in the US and Canada.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Ondine Biomedical Inc.'s technology is being utilized in Canadian healthcare and industry settings.Sub-event
Ondine Biomedical Inc. is seeking pre-NDA meeting regarding LANTERN results for trials in the US and Canada.1 source
Keep exploring
The entities involved
Related events
- Nkarta is seeking protocol amendments for its clinical trials under the FDA.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- A clinical study led by Dr. Swee Lay Thein is underway at the National Institutes of Health and is subject to oversight by the Food and Drug Administration.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- FDA issued a partial clinical hold on trials involving Biohaven Ltd. on September 11, 2026.